全文获取类型
收费全文 | 2401篇 |
免费 | 144篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 151篇 |
妇产科学 | 18篇 |
基础医学 | 221篇 |
口腔科学 | 42篇 |
临床医学 | 130篇 |
内科学 | 583篇 |
皮肤病学 | 43篇 |
神经病学 | 92篇 |
特种医学 | 133篇 |
外科学 | 434篇 |
综合类 | 49篇 |
一般理论 | 1篇 |
预防医学 | 67篇 |
眼科学 | 128篇 |
药学 | 218篇 |
中国医学 | 10篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 27篇 |
2022年 | 44篇 |
2021年 | 108篇 |
2020年 | 88篇 |
2019年 | 89篇 |
2018年 | 112篇 |
2017年 | 75篇 |
2016年 | 108篇 |
2015年 | 98篇 |
2014年 | 148篇 |
2013年 | 160篇 |
2012年 | 241篇 |
2011年 | 230篇 |
2010年 | 118篇 |
2009年 | 93篇 |
2008年 | 141篇 |
2007年 | 146篇 |
2006年 | 105篇 |
2005年 | 112篇 |
2004年 | 88篇 |
2003年 | 82篇 |
2002年 | 57篇 |
2001年 | 11篇 |
2000年 | 8篇 |
1999年 | 13篇 |
1998年 | 8篇 |
1997年 | 5篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 7篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 4篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有2554条查询结果,搜索用时 15 毫秒
71.
72.
73.
Balaram S. Takale Neha V. Desai Afsar Ali Siddiki Hemchandra K. Chaudhari Vikas N. Telvekar 《Medicinal chemistry research》2014,23(3):1387-1396
The reaction of pyrrole or dibromopyrrole-2-trichloroacetone with various amines results in the series of novel pyrrole-2-carboxamide bearing aromatic heterocycle or aryl or alkyl groups. Synthesized molecules were evaluated for their in vitro antibacterial activities. Most of the compounds exhibited potent activity against both Gram-positive and negative pathogens. 相似文献
74.
Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells 下载免费PDF全文
75.
76.
Jay R. Dave Ankush M. Dewle Suhas T. Mhaske Prashant T. Phulpagar Vikas L. Mathe Supriya E. More Ayesha A. Khan Appala Venkata Ramana Murthy Suwarna S. Datar Ajay J. Jog Megha Page Geetanjali B. Tomar 《Nanomedicine : nanotechnology, biology, and medicine》2019,15(1):218-230
Parathyroid hormone (PTH) has been a major contributor to the anabolic therapy for osteoporosis, but its delivery to bone without losing activity and avoiding adverse local effects remain a challenge. Being the natural component of bone, use of hydroxyapatite for this purpose brings a major breakthrough in synergistic anabolism. This study focuses on synthesis, characterization and evaluation of in vitro and in vivo efficacy of PTH (1-34) adsorbed hydroxyapatite nanocarrier for synergistic enhancement in the anabolic activity of PTH for bone regeneration. The negative zeta potential of this nanocarrier facilitated its affinity to the Ca2+ rich bone tissue and solubilization at low pH enhanced specific delivery of PTH to the resorption pits in osteoporotic bone. In this process, PTH retained its anabolic effect and at the same time an increase in bone mineral content indicated enhancement of the net formative effect of the PTH anabolic therapy. 相似文献
77.
Vikas Aggarwal Maggie A. Stanislawski Thomas M. Maddox Brahmajee K. Nallamothu Gary Grunwald Jill C. Adams P. Michael Ho Sunil V. Rao Ivan P. Casserly John S. Rumsfeld Emmanouil S. Brilakis Thomas T. Tsai 《Journal of the American College of Cardiology》2014
Background
Stenosis of saphenous vein grafts (SVGs) after coronary artery bypass grafting (CABG) is common and often requires percutaneous coronary interventions (PCI) for treatment. However, data for the effectiveness of drug-eluting stents (DES) versus bare-metal stents (BMS) in SVG-PCI are unclear.Objectives
This study sought to examine the association between DES versus BMS used during SVG PCI and clinical outcomes in the national Veterans Affairs integrated healthcare system.Methods
We studied a national cohort of 2,471 post-CABG veterans undergoing SVG-PCI between 2008 and 2011 at all Veterans Affairs hospitals and compared clinical outcomes of between those receiving DES and BMS. Clinical outcomes included procedural complications, myocardial infarction (MI), and all-cause mortality. Comparisons were made in a propensity-matched cohort using Cox proportional hazards regression models.Results
DES were used in 1,549 SVG-PCI patients (63%) and the use of DES increased progressively with each calendar year (50% in 2008 to 69% in 2011). Incidence of procedural complications was low and comparable in both groups (2.8% among BMS vs. 2.3% among DES patients; p = 0.54). During long-term (>2 years) follow-up, use of DES was associated with lower mortality than BMS (hazard ratio [HR]: 0.72; 95% confidence interval [CI]: 0.57 to 0.89) and similar rates of MI (HR: 0.94; 95% CI: 0.71 to 1.24) in the propensity-matched cohort.Conclusions
In a national cohort of veterans, we observed widespread and increasing use of DES during SVG-PCI. In long-term follow-up, compared with BMS, DES use was safe and effective in SVG-PCI patients. 相似文献78.
79.
80.
Graf Josephine Pape Ulrich-Frank Jann Henning Denecke Timm Arsenic Ruza Brenner Winfried Pavel Marianne Prasad Vikas 《European journal of nuclear medicine and molecular imaging》2020,47(4):881-894
European Journal of Nuclear Medicine and Molecular Imaging - One of the primary prerequisites for peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumors (NET) is the... 相似文献